Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 79, Issue 2
Volume 79, Issue 2
15 August 2024
ISSN 1058-4838
EISSN 1537-6591

Volume 79, Issue 2, 15 August 2024

In the Literature

Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages i–iv, https://doi.org/10.1093/cid/ciae301

State-of-the-Art Review

Alexandra Mendelsohn and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 287–288, https://doi.org/10.1093/cid/ciae255

Voices of ID

Darcy Wooten
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 289–291, https://doi.org/10.1093/cid/ciae089

Invited Commentary

Mark J Siedner and Paul E Sax
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 292–294, https://doi.org/10.1093/cid/ciae154

Antimicrobial Resistance and Stewardship

Ryan K Shields and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 295–304, https://doi.org/10.1093/cid/ciae171

We demonstrate how predictive modeling can mitigate inappropriate prescribing in uncomplicated urinary tract infection by providing insight into factors that increase risk of nonsusceptibility to commonly prescribed antibiotics and developing a risk categorization framework that may improve empiric treatment strategies.

Salini Mohanty and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 305–311, https://doi.org/10.1093/cid/ciae138

This study evaluated the association between social vulnerability and Streptococcus pneumoniae antimicrobial resistance in US adults. Socioeconomic status and household characteristics were the Social Vulnerability Index (SVI) themes most closely associated with Streptococcus pneumoniae antimicrobial resistance.

Kao-Ping Chua and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 312–320, https://doi.org/10.1093/cid/ciae135

In this analysis of commercial and Medicare Advantage claims, the proportion of US enrollees with ≥1 inappropriate antibiotic prescription declined after the COVID-19 outbreak but rebounded to prepandemic levels by December 2021, underscoring the continued importance of antibiotic stewardship initiatives.

Alison C Tribble and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 321–324, https://doi.org/10.1093/cid/ciae112
Stephen M Kissler and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 325–328, https://doi.org/10.1093/cid/ciae111

Bacterial Infections

Martina Ranzenigo and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 329–335, https://doi.org/10.1093/cid/ciae221

In adults, community-acquired bacterial meningitis often involves otitis, with the leading pathogen being Streptococcus pneumoniae. The presence of otitis is associated with a favorable outcome, however the impact of ear surgery on the outcome remains unclear.

Karl Oldberg and Magnus Rasmussen
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 336–338, https://doi.org/10.1093/cid/ciae222

The ESC 2023 guidelines for the management of infective endocarditis (IE) need input from microbiologists. Several aspects of microbiological diagnostics and definitions are not correct. Input from relevant areas of expertise is needed to manage IE and to write guidelines.

Clinical Practice and Policy

Braylee Grisel and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 339–347, https://doi.org/10.1093/cid/ciae162

The obligation to provide treatment to infectious patients has been debated by ethicists for the past century. In this review article, we found that ethics articles during COVID-19 were less likely to argue for a duty to treat.

Asher J Schranz and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 348–350, https://doi.org/10.1093/cid/ciae262
Addison S Hicks and Joshua C Eby
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 351–353, https://doi.org/10.1093/cid/ciae263

COVID-19/SARS CoV-2

Carolyn T Bramante and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 354–363, https://doi.org/10.1093/cid/ciae159

In a randomized trial of standard-risk adults, metformin decreased severe acute respiratory syndrome coronavirus 2 viral loads by an average of 0.56 log10 copies/mL over placebo. Metformin also caused a one-third lower risk of viral rebound at day 10.

Amy C Sherman and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 364–374, https://doi.org/10.1093/cid/ciae192

We evaluated vaccine efficacy in mildly immunocompromised study participants across 4 harmonized, randomized, placebo-controlled COVID-19 vaccine trials. There was no difference in vaccine efficacy against symptomatic or severe COVID-19 between this group and those without immunocompromising conditions.

Sarah C J Jorgensen and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 375–381, https://doi.org/10.1093/cid/ciae182

In this self-controlled risk-interval study, we found that COVID-19 vaccination was associated with reduced outpatient antibiotic prescribing among older adults. Moreover, our results suggest COVID-19 vaccination differentially reduces respiratory antibiotic prescriptions and benefits are accentuated during periods of high SARS-CoV-2 circulation.

Vida Terzić and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 382–391, https://doi.org/10.1093/cid/ciae170

The safety analysis from the randomized DisCoVeRy trial designed for hospitalized patients with moderate to severe coronavirus disease 2019 showed no significant association between remdesivir treatment compared with control in the occurrence of cardiac adverse events, including arrhythmias.

Robert L Gottlieb and Andre C Kalil
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 392–394, https://doi.org/10.1093/cid/ciae172
Courtney M Rowan and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 395–404, https://doi.org/10.1093/cid/ciae133

Children with preexisting immunocompromising conditions admitted to the pediatric intensive care unit for acute COVID-19 had higher mortality and longer duration of hospitalization than non-immunocompromised children. Reassuringly, most of these patients survived and were discharged home without new severe morbidities.

Nabin K Shrestha and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 405–411, https://doi.org/10.1093/cid/ciae132

Among 48 210 working-age Cleveland Clinic employees, the 2023–2024 formula COVID-19 vaccine was 42% effective in preventing COVID-19 before, but only 19% effective after, the JN.1 lineage became dominant.

Critical Care and Sepsis

Joseph E Marcus and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 412–419, https://doi.org/10.1093/cid/ciae120

Infectious diseases clinicians are more frequently being consulted on infections in patients receiving extracorporeal membrane oxygenation. This review summarizes the most recent guidance on antimicrobial prophylaxis, infection control, diagnosis, and treatment of nosocomial infections in this population.

Education and Training

Alejandro Díez-Vidal and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 420–429, https://doi.org/10.1093/cid/ciae285

Point-of-care ultrasound offers noninvasive, bedside, immediate-result diagnostics, enhancing physical examinations and decision-making in infectious diseases, enabling prompt antimicrobial treatment initiation, and reducing patient discomfort, necessitating specialized training for infectious disease specialists.

George Sakoulas
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 430–433, https://doi.org/10.1093/cid/ciae204

The declining interest in infectious disease among applicants may be a reflection of the current zeitgeist of medicine in particular and society in general, where revenue generation, mainstream novelty, and conspicuous self-affirmation are increasingly emphasized.

Endovascular Infections

Nicolas Fourré and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 434–442, https://doi.org/10.1093/cid/ciae315

Infective endocarditis was diagnosed in 20% of 851 episodes of streptococcal bacteremia. Sensitivity for HANDOC score >2 points, 2015 Duke-ESC, 2023 Duke-ISCVID, and 2023 Duke-ESC clinical criteria for diagnosing infective endocarditis was 95%, 65%, 81%, and 73%, respectively.

Hepatitis

Robert B Hood and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 443–450, https://doi.org/10.1093/cid/ciae157

Our nonlinear model representing HCV dynamics in the US forecasts slightly decreasing HCV infections in children <13 years old and shows that increased screening and treatment in individuals aged 13–49 years could further reduce HCV infections in young children.

HIV/AIDs

Yoko Kato and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 451–461, https://doi.org/10.1093/cid/ciae077

We found that women with HIV have higher cardiac magnetic resonance–determined myocardial fibro-inflammation, but not fibrosis or steatosis, compared with sociodemographically similar women without HIV, an association that was more pronounced in the setting of unsuppressed viremia or low nadir CD4+ count.

James Milburn and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 462–468, https://doi.org/10.1093/cid/ciae066

Cryptococcal meningitis remains a leading cause of mortality in high-HIV-prevalence settings. In Botswana, cryptococcal meningitis incidence declined with expanded antiretroviral coverage. Rapid cryptococcal antigen test was increasingly used, highlighting cryptococcal meningitis surveillance as an important metric of HIV programmatic success.

Laurence Slama and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 469–476, https://doi.org/10.1093/cid/ciae065

Pre–diabetes mellitus (DM) has been associated with negative health outcomes, including kidney disease. Among individuals with pre-DM, we show that people with human immunodeficiency virus (HIV) had a 3-fold higher risk of incident proteinuria than those without HIV.

Sara Bettonte and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 477–486, https://doi.org/10.1093/cid/ciae060

Obesity reduces the exposure of long-acting cabotegravir/rilpivirine with a significant number of morbidly obese individuals predicted to have concentrations below the target thresholds at steady-state notably for the bimonthly administration. Therapeutic drug monitoring is advised to guide dosing interval adjustment.

Catherine Bielick and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 487–497, https://doi.org/10.1093/cid/ciae051

Hospitalization and in-hospital mortality rates associated with HIV-related opportunistic infections (OIs) declined over time. The percentage of hospitalizations resulting in mortality did not change. Disparities existed for race/ethnicity subgroups, uninsured people, and US regions. Costs of HIV-related OI hospitalizations were high.

Tina Marinelli and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 498–501, https://doi.org/10.1093/cid/ciae061

Medical Microbiology

Anna Maria Peri and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 502–515, https://doi.org/10.1093/cid/ciae234

This network meta-analysis of 88 studies found that using rapid diagnostic tests in conjunction with antimicrobial stewardship programs may reduce mortality for patients with bloodstream infections compared to conventional blood culture systems, even in settings already using antimicrobial stewardship programs.

Navaneeth Narayanan and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 516–523, https://doi.org/10.1093/cid/ciae201

In 2022, the Clinical and Laboratory Standards Institute reassessed the amoxicillin-clavulanate (AMC) susceptibility criteria. Based on this contemporary reappraisal, the Enterobacterales breakpoints were retained, but dosing comments were revised. Here, we summarize the data and rationale for the AMC Enterobacterales breakpoints.

Mycobacterial Infections

Yue Zhu and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 524–533, https://doi.org/10.1093/cid/ciae329

Among patients with multidrug-resistant tuberculosis (MDR-TB) and diabetes, a higher drug exposure/susceptibility ratio correlates with favorable outcome. Poor glycemic control correlates with reduced drug exposure and unfavorable outcomes. Glycemic control and optimal drug exposure may improve the MDR-TB treatment.

Aaron Richterman and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 534–541, https://doi.org/10.1093/cid/ciae252

In this prospective cohort study of 257 people with pulmonary tuberculosis in Haiti, household food insecurity at treatment initiation was significantly associated with death or treatment failure after accounting for loss to follow-up, measured confounders, and nutritional status.

Vaccines

Joshua A Hill and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 542–554, https://doi.org/10.1093/cid/ciae291

Humoral and cellular responses were similar when SARS-CoV-2 vaccination was initiated <4 months versus 4–12 months after cellular therapy. Pre–cellular therapy SARS-CoV-2 vaccination and baseline B-cell count were key predictors of post–cellular therapy immunity.

Tasnim Hasan and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 555–561, https://doi.org/10.1093/cid/ciae209

This scoping review identified all published outbreaks of vaccine-preventable diseases in healthcare workers between 2000 and 2022. Vaccine-preventable diseases were the 10 diseases for which vaccines are recommended for healthcare workers by the World Health Organization.

Rachel K Russ and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 562–563, https://doi.org/10.1093/cid/ciae320

Photo Quiz

Shinsuke Kikuchi and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 564–567, https://doi.org/10.1093/cid/ciae076

Correspondence

Paul Robertson
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Page 568, https://doi.org/10.1093/cid/ciad751
Annette C Westgeest and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 568–569, https://doi.org/10.1093/cid/ciad753
Tim Crocker-Buque and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 569–570, https://doi.org/10.1093/cid/ciad767
Takahiro Matsuo and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 571–572, https://doi.org/10.1093/cid/ciad768
Drew J Winston and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Page 572, https://doi.org/10.1093/cid/ciad769
Ryan C Maves
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Page 573, https://doi.org/10.1093/cid/ciad771
Kellie J Goodlet and Michael D Nailor
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 573–574, https://doi.org/10.1093/cid/ciad772
Michael R Rose and David W Dowdy
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 574–575, https://doi.org/10.1093/cid/ciad774
Chia-Yu Chiu and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 575–576, https://doi.org/10.1093/cid/ciad775
Kyle J Popovich and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 576–577, https://doi.org/10.1093/cid/ciad777
Emmanuel Dudoignon and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages 577–579, https://doi.org/10.1093/cid/ciad781

Correction

Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Page 580, https://doi.org/10.1093/cid/ciae311

State-of-the-Art Review

Alexandra Mendelsohn and others
Clinical Infectious Diseases, Volume 79, Issue 2, 15 August 2024, Pages e1–e10, https://doi.org/10.1093/cid/ciae250

Delusional infestation is a condition in which patients have a fixed, false belief that they are infested with living creatures or nonliving objects. This paper provides evidence-based guidance for infectious diseases clinicians in the evaluation and management of these patients.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close